Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Belly, MJ; Tiede, H; Morty, RE; Schulz, R; Voswinckel, R; Tanislav, C; Olschewski, H; Ghofrani, HA; Seeger, W; Reichenberger, F.
HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance?
J Heart Lung Transplant. 2012; 31(10):1109-1114
Doi: 10.1016/j.healun.2012.08.014
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Olschewski Horst
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Patients with pulmonary arterial hypertension (PAH) exhibit impaired glucose metabolism and increased insulin resistance. The clinical consequences of these metabolic changes are not known. METHODS: We assessed HbA(1c) levels in 115 patients newly diagnosed with PAH (79 females and 36 males; mean age 49.2 years; idiopathic n = 67, collagen vascular disease n = 16, congenital heart defect n = 19, pulmonary veno-occlusive disease n = 8, portopulmonary n = 5). No patients had diabetes or were receiving anti-diabetic medication or systemic steroids. After initiation of pulmonary vasoactive treatment, patients remained in long-term follow-up. RESULTS: Initially, patients were in an advanced stage of disease (mean pulmonary arterial pressure 53 +/- 18 mm Hg, cardiac index 2.3 +/- 0,8 liters/min/m(2)) with a 6-minute-walk distance of 337 +/- 123 meters, and in NYHA Functional Class 3.0 +/- 0.7. The HbA(1c) was 5.73 +/- 0.75%. A moderate but statistically significant positive correlation was observed between HbA(1c) levels and BNP (r(p) = 0.41, p = 0.014), but no correlation was found with hemodynamics or 6-minute-walk distance. The 5-year survival rate for the entire group was 68%. Kaplan-Meier analysis and multivariate Cox proportional hazard models correcting for demographic and clinical covariates revealed that patients with HbA(1c) <5.7% had a significantly better 5-year survival compared with those having higher initial values (85.1% vs 55.9%; log rank p = 0.002). HbA(1c) was a predictor of all-cause mortality with a hazard ratio of 2.23 (95% CI 1.06 to 4.70; p = 0.034) per 1-unit increase of HbA(1c). CONCLUSIONS: In patients with pulmonary arterial hypertension, the HbA(1c) level at time of diagnosis is an independent predictor of long-term prognosis. J Heart Lung Transplant 2012;31:1109-14 (C) 2012 International Society for Heart and Lung Transplantation. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Aged -
- Biological Markers - blood
- Female -
- Follow-Up Studies -
- Hemoglobin A, Glycosylated - metabolism
- Humans -
- Hypertension, Pulmonary - blood
- Kaplan-Meier Estimate -
- Longitudinal Studies -
- Male -
- Middle Aged -
- Prognosis -
- Proportional Hazards Models -
- Survival Rate -
- Find related publications in this database (Keywords)
- glucose metabolism disorder
- glycosylated hemoglobin A(1c)
- pulmonary arterial hypertension
- insulin resistance
- impaired glucose metabolism
- diabetes mellitus